237 related articles for article (PubMed ID: 34319220)
1. Identification of potential ZIKV NS2B-NS3 protease inhibitors from
Thirumoorthy G; Tarachand SP; Nagella P; Veerappa Lakshmaiah V
J Biomol Struct Dyn; 2022; 40(21):11203-11215. PubMed ID: 34319220
[No Abstract] [Full Text] [Related]
2. Development of NS2B-NS3 protease inhibitor that impairs Zika virus replication.
Lin WW; Huang YJ; Wang YT; Lin YS; Mazibuko N; Chen CS; Cheng TL; Chang CS; Leu YL; Chen CY; Chuang CH
Virus Res; 2023 May; 329():199092. PubMed ID: 36965673
[TBL] [Abstract][Full Text] [Related]
3. pH and non-covalent ligand binding modulate Zika virus NS2B/NS3 protease binding site residues: Discoveries from MD and constant pH MD simulations.
Santos LH; Caffarena ER; Ferreira RS
J Biomol Struct Dyn; 2022; 40(20):10359-10372. PubMed ID: 34180376
[TBL] [Abstract][Full Text] [Related]
4. NS2B-NS3 protease inhibitors as promising compounds in the development of antivirals against Zika virus: A systematic review.
Nunes DAF; Santos FRDS; da Fonseca STD; de Lima WG; Nizer WSDC; Ferreira JMS; de Magalhães JC
J Med Virol; 2022 Feb; 94(2):442-453. PubMed ID: 34636434
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the Zika virus two-component NS2B-NS3 protease and structure-assisted identification of allosteric small-molecule antagonists.
Shiryaev SA; Farhy C; Pinto A; Huang CT; Simonetti N; Elong Ngono A; Dewing A; Shresta S; Pinkerton AB; Cieplak P; Strongin AY; Terskikh AV
Antiviral Res; 2017 Jul; 143():218-229. PubMed ID: 28461069
[TBL] [Abstract][Full Text] [Related]
6. Structure-based discovery of clinically approved drugs as Zika virus NS2B-NS3 protease inhibitors that potently inhibit Zika virus infection in vitro and in vivo.
Yuan S; Chan JF; den-Haan H; Chik KK; Zhang AJ; Chan CC; Poon VK; Yip CC; Mak WW; Zhu Z; Zou Z; Tee KM; Cai JP; Chan KH; de la Peña J; Pérez-Sánchez H; Cerón-Carrasco JP; Yuen KY
Antiviral Res; 2017 Sep; 145():33-43. PubMed ID: 28712942
[TBL] [Abstract][Full Text] [Related]
7. Identification of novel Zika virus NS3 protease inhibitors with different inhibition modes by integrative experimental and computational approaches.
Andrade MA; Mottin M; Sousa BKP; Barbosa JARG; Dos Santos Azevedo C; Lasse Silva C; Gonçalves de Andrade M; Motta FN; Maulay-Bailly C; Amand S; Santana JM; Horta Andrade C; Grellier P; Bastos IMD
Biochimie; 2023 Sep; 212():143-152. PubMed ID: 37088408
[TBL] [Abstract][Full Text] [Related]
8. Identification of a C2-symmetric diol based human immunodeficiency virus protease inhibitor targeting Zika virus NS2B-NS3 protease.
Akaberi D; Chinthakindi PK; Båhlström A; Palanisamy N; Sandström A; Lundkvist Å; Lennerstrand J
J Biomol Struct Dyn; 2020 Nov; 38(18):5526-5536. PubMed ID: 31880199
[TBL] [Abstract][Full Text] [Related]
9. The discovery of Zika virus NS2B-NS3 inhibitors with antiviral activity via an integrated virtual screening approach.
Mirza MU; Alanko I; Vanmeert M; Muzzarelli KM; Salo-Ahen OMH; Abdullah I; Kovari IA; Claes S; De Jonghe S; Schols D; Schinazi RF; Kovari LC; Trant JF; Ahmad S; Froeyen M
Eur J Pharm Sci; 2022 Aug; 175():106220. PubMed ID: 35618201
[TBL] [Abstract][Full Text] [Related]
10. The Inhibition of NS2B/NS3 Protease: A New Therapeutic Opportunity to Treat Dengue and Zika Virus Infection.
Starvaggi J; Previti S; Zappalà M; Ettari R
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673962
[TBL] [Abstract][Full Text] [Related]
11. In silico evaluation of inhibitory potential of triterpenoids from Azadirachta indica against therapeutic target of dengue virus, NS2B-NS3 protease.
Dwivedi VD; Tripathi IP; Mishra SK
J Vector Borne Dis; 2016; 53(2):156-61. PubMed ID: 27353586
[TBL] [Abstract][Full Text] [Related]
12. Allosteric Inhibitors of Zika Virus NS2B-NS3 Protease Targeting Protease in "Super-Open" Conformation.
Meewan I; Shiryaev SA; Kattoula J; Huang CT; Lin V; Chuang CH; Terskikh AV; Abagyan R
Viruses; 2023 Apr; 15(5):. PubMed ID: 37243192
[TBL] [Abstract][Full Text] [Related]
13. Allosteric quinoxaline-based inhibitors of the flavivirus NS2B/NS3 protease.
Zephyr J; Rao DN; Johnson C; Shaqra AM; Nalivaika EA; Jordan A; Kurt Yilmaz N; Ali A; Schiffer CA
Bioorg Chem; 2023 Feb; 131():106269. PubMed ID: 36446201
[TBL] [Abstract][Full Text] [Related]
14. Zika virus NS2B/NS3 proteinase: A new target for an old drug - Suramin a lead compound for NS2B/NS3 proteinase inhibition.
Coronado MA; Eberle RJ; Bleffert N; Feuerstein S; Olivier DS; de Moraes FR; Willbold D; Arni RK
Antiviral Res; 2018 Dec; 160():118-125. PubMed ID: 30393012
[TBL] [Abstract][Full Text] [Related]
15. MD simulations reveal alternate conformations of the oxyanion hole in the Zika virus NS2B/NS3 protease.
Ren J; Lee H; Kotak A; Johnson ME
Proteins; 2020 Feb; 88(2):345-354. PubMed ID: 31461176
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the inhibitory potency of anti-dengue phytocompounds against DENV-2 NS2B-NS3 protease: virtual screening, ADMET profiling and molecular dynamics simulation investigations.
Purohit P; Barik D; Agasti S; Panda M; Meher BR
J Biomol Struct Dyn; 2024 Apr; 42(6):2990-3009. PubMed ID: 37194462
[TBL] [Abstract][Full Text] [Related]
17. Crystal structure of unlinked NS2B-NS3 protease from Zika virus.
Zhang Z; Li Y; Loh YR; Phoo WW; Hung AW; Kang C; Luo D
Science; 2016 Dec; 354(6319):1597-1600. PubMed ID: 27940580
[TBL] [Abstract][Full Text] [Related]
18. Discovery of New Zika Protease and Polymerase Inhibitors through the Open Science Collaboration Project OpenZika.
Mottin M; de Paula Sousa BK; de Moraes Roso Mesquita NC; de Oliveira KIZ; Noske GD; Sartori GR; de Oliveira Albuquerque A; Urbina F; Puhl AC; Moreira-Filho JT; Souza GE; Guido RVC; Muratov E; Neves BJ; Martins da Silva JH; Clark AE; Siqueira-Neto JL; Perryman AL; Oliva G; Ekins S; Andrade CH
J Chem Inf Model; 2022 Dec; 62(24):6825-6843. PubMed ID: 36239304
[TBL] [Abstract][Full Text] [Related]
19. Identification and characterization of new potent inhibitors of dengue virus NS5 proteinase from Andrographis paniculata supercritical extracts on in animal cell culture and in silico approaches.
Kaushik S; Dar L; Kaushik S; Yadav JP
J Ethnopharmacol; 2021 Mar; 267():113541. PubMed ID: 33152438
[TBL] [Abstract][Full Text] [Related]
20. Identification of potential Zika virus NS2B-NS3 protease inhibitors via docking, molecular dynamics and consensus scoring-based virtual screening.
Bowen LR; Li DJ; Nola DT; Anderson MO; Heying M; Groves AT; Eagon S
J Mol Model; 2019 Jun; 25(7):194. PubMed ID: 31209577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
